Vor Biopharma (VOR)

• Market cap: $1.06B
• 1 day: -2.15%
• 5 days: 1.45%
• 1 month: 5.22%
• 3 months: 39.49%
• 6 months: 39.89%
• Year to date: 68.13%
• 1 year: -58.36%
• 5 years: -92.82%
• 10 years: -97.39%
• Sector: Healthcare
• Industry: Biotechnology

About: Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Employees: 76